Targeted therapy is听a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
The global Targeted Small Molecule Therapy market is projected to reach US$ 97020 million in 2029, increasing from US$ 50220 million in 2022, with the CAGR of 9.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Targeted Small Molecule Therapy 91制片厂.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Targeted Small Molecule Therapy market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere
Segment by Type
Sorafenib
Lenvatinib
Regorafenib
Osimertinib
Anlotinib
Alectinib
Other
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Targeted Small Molecule Therapy report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Small Molecule Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sorafenib
1.2.3 Lenvatinib
1.2.4 Regorafenib
1.2.5 Osimertinib
1.2.6 Anlotinib
1.2.7 Alectinib
1.2.8 Other
1.3 Market by Application
1.3.1 Global Targeted Small Molecule Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Small Molecule Therapy Market Perspective (2018-2029)
2.2 Targeted Small Molecule Therapy Growth Trends by Region
2.2.1 Global Targeted Small Molecule Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Targeted Small Molecule Therapy Historic Market Size by Region (2018-2023)
2.2.3 Targeted Small Molecule Therapy Forecasted Market Size by Region (2024-2029)
2.3 Targeted Small Molecule Therapy Market Dynamics
2.3.1 Targeted Small Molecule Therapy Industry Trends
2.3.2 Targeted Small Molecule Therapy Market Drivers
2.3.3 Targeted Small Molecule Therapy Market Challenges
2.3.4 Targeted Small Molecule Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Small Molecule Therapy Players by Revenue
3.1.1 Global Top Targeted Small Molecule Therapy Players by Revenue (2018-2023)
3.1.2 Global Targeted Small Molecule Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Targeted Small Molecule Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Targeted Small Molecule Therapy Revenue
3.4 Global Targeted Small Molecule Therapy Market Concentration Ratio
3.4.1 Global Targeted Small Molecule Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Small Molecule Therapy Revenue in 2022
3.5 Targeted Small Molecule Therapy Key Players Head office and Area Served
3.6 Key Players Targeted Small Molecule Therapy Product Solution and Service
3.7 Date of Enter into Targeted Small Molecule Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Small Molecule Therapy Breakdown Data by Type
4.1 Global Targeted Small Molecule Therapy Historic Market Size by Type (2018-2023)
4.2 Global Targeted Small Molecule Therapy Forecasted Market Size by Type (2024-2029)
5 Targeted Small Molecule Therapy Breakdown Data by Application
5.1 Global Targeted Small Molecule Therapy Historic Market Size by Application (2018-2023)
5.2 Global Targeted Small Molecule Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Targeted Small Molecule Therapy Market Size (2018-2029)
6.2 North America Targeted Small Molecule Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Targeted Small Molecule Therapy Market Size by Country (2018-2023)
6.4 North America Targeted Small Molecule Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Small Molecule Therapy Market Size (2018-2029)
7.2 Europe Targeted Small Molecule Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Targeted Small Molecule Therapy Market Size by Country (2018-2023)
7.4 Europe Targeted Small Molecule Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Small Molecule Therapy Market Size (2018-2029)
8.2 Asia-Pacific Targeted Small Molecule Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Targeted Small Molecule Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Targeted Small Molecule Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Small Molecule Therapy Market Size (2018-2029)
9.2 Latin America Targeted Small Molecule Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Targeted Small Molecule Therapy Market Size by Country (2018-2023)
9.4 Latin America Targeted Small Molecule Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Small Molecule Therapy Market Size (2018-2029)
10.2 Middle East & Africa Targeted Small Molecule Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Targeted Small Molecule Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Targeted Small Molecule Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Targeted Small Molecule Therapy Introduction
11.1.4 Bayer Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.1.5 Bayer Recent Development
11.2 Eisai
11.2.1 Eisai Company Detail
11.2.2 Eisai Business Overview
11.2.3 Eisai Targeted Small Molecule Therapy Introduction
11.2.4 Eisai Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.2.5 Eisai Recent Development
11.3 Zelgen
11.3.1 Zelgen Company Detail
11.3.2 Zelgen Business Overview
11.3.3 Zelgen Targeted Small Molecule Therapy Introduction
11.3.4 Zelgen Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.3.5 Zelgen Recent Development
11.4 Cipla
11.4.1 Cipla Company Detail
11.4.2 Cipla Business Overview
11.4.3 Cipla Targeted Small Molecule Therapy Introduction
11.4.4 Cipla Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.4.5 Cipla Recent Development
11.5 Natco Pharma
11.5.1 Natco Pharma Company Detail
11.5.2 Natco Pharma Business Overview
11.5.3 Natco Pharma Targeted Small Molecule Therapy Introduction
11.5.4 Natco Pharma Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.5.5 Natco Pharma Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Targeted Small Molecule Therapy Introduction
11.6.4 AstraZeneca Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Targeted Small Molecule Therapy Introduction
11.7.4 Novartis Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.7.5 Novartis Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche Targeted Small Molecule Therapy Introduction
11.8.4 Roche Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.8.5 Roche Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Targeted Small Molecule Therapy Introduction
11.9.4 Bristol-Myers Squibb Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Targeted Small Molecule Therapy Introduction
11.10.4 Pfizer Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.10.5 Pfizer Recent Development
11.11 BEACON Pharma
11.11.1 BEACON Pharma Company Detail
11.11.2 BEACON Pharma Business Overview
11.11.3 BEACON Pharma Targeted Small Molecule Therapy Introduction
11.11.4 BEACON Pharma Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.11.5 BEACON Pharma Recent Development
11.12 Jiangxi Shanxiang
11.12.1 Jiangxi Shanxiang Company Detail
11.12.2 Jiangxi Shanxiang Business Overview
11.12.3 Jiangxi Shanxiang Targeted Small Molecule Therapy Introduction
11.12.4 Jiangxi Shanxiang Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.12.5 Jiangxi Shanxiang Recent Development
11.13 Yao Pharma
11.13.1 Yao Pharma Company Detail
11.13.2 Yao Pharma Business Overview
11.13.3 Yao Pharma Targeted Small Molecule Therapy Introduction
11.13.4 Yao Pharma Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.13.5 Yao Pharma Recent Development
11.14 CSPC
11.14.1 CSPC Company Detail
11.14.2 CSPC Business Overview
11.14.3 CSPC Targeted Small Molecule Therapy Introduction
11.14.4 CSPC Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.14.5 CSPC Recent Development
11.15 CHIATAI Tianqing
11.15.1 CHIATAI Tianqing Company Detail
11.15.2 CHIATAI Tianqing Business Overview
11.15.3 CHIATAI Tianqing Targeted Small Molecule Therapy Introduction
11.15.4 CHIATAI Tianqing Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.15.5 CHIATAI Tianqing Recent Development
11.16 Simcere
11.16.1 Simcere Company Detail
11.16.2 Simcere Business Overview
11.16.3 Simcere Targeted Small Molecule Therapy Introduction
11.16.4 Simcere Revenue in Targeted Small Molecule Therapy Business (2018-2023)
11.16.5 Simcere Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere
听
听
*If Applicable.